How do pediatric patients perceive adverse drug events of anticonvulsant drugs? A survey

被引:6
|
作者
Neininger, Martina Patrizia [1 ,2 ]
Woltermann, Sarah [1 ,2 ,3 ]
Jeschke, Sarah [4 ]
Herziger, Birthe [4 ]
Mueller, Ruth Melinda [4 ]
Kiess, Wieland [3 ]
Bertsche, Thilo [1 ,2 ]
Bertsche, Astrid [3 ,4 ]
机构
[1] Univ Leipzig, Med Fac, Inst Pharm, Drug Safety Ctr, Bruderstr 32, D-04103 Leipzig, Germany
[2] Univ Leipzig, Med Fac, Inst Pharm, Clin Pharm, Bruderstr 32, D-04103 Leipzig, Germany
[3] Univ Hosp Children & Adolescents, Ctr Pediat Res, Liebigstr 20a, D-04103 Leipzig, Germany
[4] Univ Hosp Children & Adolescents, Neuropaediat, Ernst Heydemann Str 8, D-18057 Rostock, Germany
关键词
Adverse drug events (ADEs); Anticonvulsants; Children; Adolescents; Perceptions; Interview; SUDDEN UNEXPECTED DEATH; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; WEIGHT-GAIN; EPILEPSY; CHILDREN; ADOLESCENTS; OXCARBAZEPINE; VALPROATE; FEAR;
D O I
10.1007/s00431-020-03571-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Anticonvulsant drugs have a high risk of adverse drug events. Little is known about the perception of those events by pediatric patients. We performed a survey in the neuropediatric departments of two university hospitals. Using a questionnaire, we interviewed patients aged 6-18 years with current anticonvulsant treatment regarding (i) their fears about potential adverse drug events, (ii) experienced adverse drug events, and (iii) perceived burden of experienced adverse drug events. One hundred patients took part in the interview. (i) 40 (40%) expressed fears that the medication could harm them. Eighteen of 40 (45%) named fears concerning specific adverse drug events. Of those, 12/18 (67%) feared neurologic or psychiatric symptoms. (ii) 37 (37%) of children described altogether 60 experienced adverse drug events. Of those, 38 (63%) concerned neurologic or psychiatric symptoms. (iii) 32/37 (82%) children who experienced adverse drug events felt bothered by the experienced event. Among others, they described an emotional burden (11/37, 30%), and restrictions in school performance (8/37, 22%) and favorite leisure activities (4/37, 11%). Conclusion: School-aged children are well able to describe adverse drug events of their anticonvulsant medication. Almost two thirds of the described events concern neurologic or psychiatric symptoms that cause an emotional burden and restrictions according to the patients. What is Known: center dot Anticonvulsants have a high potential of adverse drug events. center dot In an earlier survey, parents expressed fears of severe adverse drug events such as liver failure, which seldom occur, and reported a high number of neurological and psychological adverse drug events. What is New: center dot Many children fear that their anticonvulsants could harm them, and they fear and experience neurological and psychological adverse drug events. center dot According to the children, adverse drug events cause an emotional burden and restrictions in school performance and favorite leisure activities.
引用
下载
收藏
页码:1413 / 1420
页数:8
相关论文
共 50 条
  • [1] How do pediatric patients perceive adverse drug events of anticonvulsant drugs? A survey
    Martina Patrizia Neininger
    Sarah Woltermann
    Sarah Jeschke
    Birthe Herziger
    Ruth Melinda Müller
    Wieland Kiess
    Thilo Bertsche
    Astrid Bertsche
    European Journal of Pediatrics, 2020, 179 : 1413 - 1420
  • [2] How do parents perceive adverse drug events of their children's anticonvulsant medication?
    Bach, V. A.
    Neininger, M. P.
    Spindler, U. P.
    Hotopp, L. C.
    Hornemann, F.
    Syrbe, S.
    Merkenschlager, A.
    Kiess, W.
    Bernhard, M. K.
    Bertsche, T.
    Bertsche, A.
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2018, 22 (03) : 427 - 433
  • [3] ADVERSE EVENTS ASSOCIATED WITH ANTICONVULSANT DRUG FORMULATION SUBSTITUTION IN PEDIATRIC AND ADULT EPILEPSY PATIENTS
    Paolini, Jan
    Chu-Shore, C.
    Macdonald, C.
    Bruno, P.
    Thibert, R.
    Thiele, E.
    EPILEPSIA, 2009, 50 : 259 - 260
  • [4] Adverse drug events and adverse drug reactions in pediatric patients: Overview
    Giacoia, GP
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (09): : 625 - 626
  • [5] Clinical correlates of psychiatric adverse events of anticonvulsant drugs in patients with epilepsy
    Mula, M.
    Trimble, M. R.
    Sander, J. W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S535 - S535
  • [6] Adverse drug events in pediatric outpatients
    Kaushal, Rainu
    Goldmann, Donald A.
    Keohane, Carol A.
    Christino, Melissa
    Honour, Melissa
    Hale, Andrea S.
    Zigmont, Katherine
    Soleymani, Lisa Lehmann
    Perrin, James
    Bates, David W.
    AMBULATORY PEDIATRICS, 2007, 7 (05) : 383 - 389
  • [7] Why Do Hospital Patients Experience Adverse Drug Events?
    Dequito, A.
    Mol, P.
    van Doormaal, J.
    Zaal, R.
    van den Bemt, P.
    Haaijer-Ruskamp, F.
    Kosterink, J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S200 - S201
  • [8] Patterns of anticonvulsant use and adverse drug events in older adults
    Moura, Lidia M. V. R.
    Smith, Jason R.
    Yan, Zhiyu
    Blacker, Deborah
    Schwamm, Lee H.
    Newhouse, Joseph P.
    Hernandez-Diaz, Sonia
    Hsu, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (01) : 28 - 36
  • [9] Adverse drug events in patients treated with cardiovascular drugs and anticoagulants.
    Zaidenstein, R
    Golik, A
    Eyal, S
    Efrati, S
    Akivision, L
    Koren, M
    Fishman, S
    Avni, B
    Uriel, N
    Moravski, G
    Nagornov, V
    Simantov, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P64 - P64
  • [10] Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants
    Zaidenstein, R
    Eyal, S
    Efrati, S
    Akivison, L
    Michowitz, MK
    Nagornov, V
    Golik, A
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (03) : 235 - 238